Efficacy of PLDD Versus ESI in the Treatment of Lumbar Radicular Pain
Launched by OSIJEK UNIVERSITY HOSPITAL · Oct 26, 2022
Trial Information
Current as of May 21, 2025
Unknown status
Keywords
ClinConnect Summary
The hypothesis is that:
* there will be no difference in effectiveness in reducing the intensity of pain, improving the quality of life, reducing the degree of disability, reducing neuropathic pain, reducing anxiety and depression, and improving the quality of sleep in the treatment of lumbar radicular pain caused by disc herniation without discoradicular contact, but PLDD will be more effective in patients where there is discorradicular contact
* PLDD will lead to a greater reduction in serum levels of inflammatory markers in patients with nerve compression by intervertebral disc herniati...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 60
- • Signing informed consent
- • Unilateral lumbar radicular pain
- • Subjects who do not responds to conservative treatment
- • Disc herniation at one level
- • MR verified disc herniation
- • Pain intensity measured by VAS scale, from 0 - 10, \>5
- Exclusion Criteria:
- • Subjects younger than 18 and older than 65 years
- • Refusal of the subjects to participate in the research
- • Central stenosis of the lumbar canal
- • Lumbar radicular pain caused by causes other than intervertebral disc herniation
- • Pregnancy
- • Allergy to steroids, local anesthetics, fentanyl, midazolam and contrast medium
- • Positive history of prolonged bleeding
- • Local or systemic infection
- • Previous lumbar spine surgery7
- • Opioid abuse
- • Proven inflammatory rheumatic disease and inflammatory bowel disease in the active phase
- • Other acute infections
About Osijek University Hospital
Osijek University Hospital is a leading healthcare institution dedicated to advancing medical research and patient care. Located in Osijek, Croatia, the hospital integrates clinical practice with academic excellence, fostering a collaborative environment for healthcare professionals and researchers. With a commitment to innovation, Osijek University Hospital actively sponsors clinical trials aimed at evaluating new therapies and improving treatment outcomes across various medical fields. By leveraging state-of-the-art facilities and a multidisciplinary team, the hospital plays a pivotal role in contributing to the advancement of medical knowledge and enhancing the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Osijek, , Croatia
Patients applied
Trial Officials
Dino Budrovac, MD
Principal Investigator
UH Osijek
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials